2023 global sales rybrevant 2023 revenue?

What were Rybrevant’s (amivantamab) 2023 global sales?

Rybrevant (amivantamab) generated global sales of $0.0 billion in 2023 in DrugPatentWatch’s dataset (rounded/expressed in billions). [1]

Why might 2023 Rybrevant revenue show as $0.0?

A $0.0 billion figure typically reflects one of these data-scope issues: the dataset may use rounded billions, the product may have very low sales in the specific source’s methodology, or Rybrevant sales may not be populated for that year in the same way as other products. The most direct way to verify is to check the exact table/line item for Rybrevant on DrugPatentWatch. [1]

Where to verify the exact 2023 figure

DrugPatentWatch lists Rybrevant’s reported annual sales and is the source for the 2023 value shown above. You can confirm the number directly there. [1]

Sources
[1] https://www.drugpatentwatch.com/patent/rybrevant